nodes	percent_of_prediction	percent_of_DWPC	metapath
Desoximetasone—Corticosteroid Hormone Receptor Agonists—Prednisone—prostate cancer	0.353	1	CiPCiCtD
Desoximetasone—Prednisone—prostate cancer	0.239	1	CrCtD
Desoximetasone—NR3C1—prostate cancer	0.153	1	CbGaD
Desoximetasone—NR3C1—Prednisone—prostate cancer	0.0336	1	CbGbCtD
Desoximetasone—Testolactone—Estrone—prostate cancer	0.0296	0.169	CrCrCtD
Desoximetasone—Testolactone—Prednisone—prostate cancer	0.0077	0.0438	CrCrCtD
Desoximetasone—Fluocortolone—Prednisone—prostate cancer	0.00747	0.0426	CrCrCtD
Desoximetasone—Alclometasone—Prednisone—prostate cancer	0.00727	0.0414	CrCrCtD
Desoximetasone—Budesonide—Prednisone—prostate cancer	0.00707	0.0403	CrCrCtD
Desoximetasone—Amcinonide—Prednisone—prostate cancer	0.00707	0.0403	CrCrCtD
Desoximetasone—Clobetasol propionate—Prednisone—prostate cancer	0.00689	0.0392	CrCrCtD
Desoximetasone—Desonide—Prednisone—prostate cancer	0.00689	0.0392	CrCrCtD
Desoximetasone—Diflorasone—Prednisone—prostate cancer	0.00689	0.0392	CrCrCtD
Desoximetasone—Flunisolide—Prednisone—prostate cancer	0.00689	0.0392	CrCrCtD
Desoximetasone—Fludrocortisone—Prednisone—prostate cancer	0.00689	0.0392	CrCrCtD
Desoximetasone—Paramethasone—Prednisone—prostate cancer	0.00672	0.0383	CrCrCtD
Desoximetasone—Mometasone—Prednisone—prostate cancer	0.0064	0.0364	CrCrCtD
Desoximetasone—Loteprednol—Prednisone—prostate cancer	0.0064	0.0364	CrCrCtD
Desoximetasone—Fluprednidene Acetate—Prednisone—prostate cancer	0.0064	0.0364	CrCrCtD
Desoximetasone—Triamcinolone—Prednisone—prostate cancer	0.0064	0.0364	CrCrCtD
Desoximetasone—Fluorometholone—Prednisone—prostate cancer	0.0064	0.0364	CrCrCtD
Desoximetasone—Dexamethasone—Prednisone—prostate cancer	0.00625	0.0356	CrCrCtD
Desoximetasone—Rimexolone—Prednisone—prostate cancer	0.00625	0.0356	CrCrCtD
Desoximetasone—Betamethasone—Prednisone—prostate cancer	0.00625	0.0356	CrCrCtD
Desoximetasone—Methylprednisolone—Prednisone—prostate cancer	0.00598	0.0341	CrCrCtD
Desoximetasone—Prednisolone—Prednisone—prostate cancer	0.00585	0.0333	CrCrCtD
Desoximetasone—Hydrocortisone—Prednisone—prostate cancer	0.00562	0.032	CrCrCtD
Desoximetasone—Pigmentation skin—Estradiol—prostate cancer	0.0013	0.0491	CcSEcCtD
Desoximetasone—Application site irritation—Estradiol—prostate cancer	0.000853	0.0323	CcSEcCtD
Desoximetasone—Secondary adrenocortical insufficiency—Prednisone—prostate cancer	0.000758	0.0287	CcSEcCtD
Desoximetasone—Pigmentation skin—Prednisone—prostate cancer	0.00072	0.0273	CcSEcCtD
Desoximetasone—NR3C1—urine—prostate cancer	0.000714	0.348	CbGeAlD
Desoximetasone—Pigmentation disorder—Estradiol—prostate cancer	0.000709	0.0269	CcSEcCtD
Desoximetasone—Allergic contact dermatitis—Estradiol—prostate cancer	0.000677	0.0257	CcSEcCtD
Desoximetasone—Acne—Estradiol valerate/Dienogest—prostate cancer	0.000664	0.0251	CcSEcCtD
Desoximetasone—Cushing's syndrome—Prednisone—prostate cancer	0.000579	0.0219	CcSEcCtD
Desoximetasone—Telangiectasia—Prednisone—prostate cancer	0.000558	0.0211	CcSEcCtD
Desoximetasone—Pigmentation disorder—Etoposide—prostate cancer	0.00055	0.0208	CcSEcCtD
Desoximetasone—NR3C1—Regulation of Androgen receptor activity—TMPRSS2—prostate cancer	0.000532	0.0364	CbGpPWpGaD
Desoximetasone—Acneiform eruption—Prednisone—prostate cancer	0.00052	0.0197	CcSEcCtD
Desoximetasone—Cataract subcapsular—Prednisone—prostate cancer	0.000504	0.0191	CcSEcCtD
Desoximetasone—NR3C1—Regulation of Androgen receptor activity—HOXB13—prostate cancer	0.000452	0.031	CbGpPWpGaD
Desoximetasone—Pigmentation disorder—Capecitabine—prostate cancer	0.000442	0.0168	CcSEcCtD
Desoximetasone—Skin atrophy—Prednisone—prostate cancer	0.000435	0.0165	CcSEcCtD
Desoximetasone—Acne—Ethinyl Estradiol—prostate cancer	0.000431	0.0163	CcSEcCtD
Desoximetasone—Skin striae—Prednisone—prostate cancer	0.000413	0.0157	CcSEcCtD
Desoximetasone—NR3C1—FOXA2 and FOXA3 transcription factor networks—FOXA3—prostate cancer	0.000398	0.0273	CbGpPWpGaD
Desoximetasone—Pigmentation disorder—Prednisone—prostate cancer	0.000394	0.0149	CcSEcCtD
Desoximetasone—Dermatitis acneiform—Prednisone—prostate cancer	0.000385	0.0146	CcSEcCtD
Desoximetasone—Hyperglycaemia—Abiraterone—prostate cancer	0.000368	0.014	CcSEcCtD
Desoximetasone—Acne—Goserelin—prostate cancer	0.000355	0.0134	CcSEcCtD
Desoximetasone—Secondary infection—Epirubicin—prostate cancer	0.00035	0.0133	CcSEcCtD
Desoximetasone—Hypertrichosis—Prednisone—prostate cancer	0.000346	0.0131	CcSEcCtD
Desoximetasone—NR3C1—Regulation of Androgen receptor activity—KLK3—prostate cancer	0.000343	0.0235	CbGpPWpGaD
Desoximetasone—NR3C1—Adipogenesis—KLF15—prostate cancer	0.000343	0.0235	CbGpPWpGaD
Desoximetasone—NR3C1—Adipogenesis—SPOCK1—prostate cancer	0.000343	0.0235	CbGpPWpGaD
Desoximetasone—Hyperglycaemia—Nilutamide—prostate cancer	0.000336	0.0127	CcSEcCtD
Desoximetasone—Hyperglycaemia—Flutamide—prostate cancer	0.000335	0.0127	CcSEcCtD
Desoximetasone—NR3C1—FOXA2 and FOXA3 transcription factor networks—FOXA1—prostate cancer	0.000324	0.0222	CbGpPWpGaD
Desoximetasone—Secondary infection—Doxorubicin—prostate cancer	0.000324	0.0123	CcSEcCtD
Desoximetasone—NR3C1—Regulation of Androgen receptor activity—KLK2—prostate cancer	0.000322	0.0221	CbGpPWpGaD
Desoximetasone—Leukoderma—Prednisone—prostate cancer	0.000309	0.0117	CcSEcCtD
Desoximetasone—Pigmentation disorder—Epirubicin—prostate cancer	0.000308	0.0117	CcSEcCtD
Desoximetasone—Hyperglycaemia—Degarelix—prostate cancer	0.000301	0.0114	CcSEcCtD
Desoximetasone—Pigmentation disorder—Doxorubicin—prostate cancer	0.000285	0.0108	CcSEcCtD
Desoximetasone—Hyperglycaemia—Cabazitaxel—prostate cancer	0.000283	0.0107	CcSEcCtD
Desoximetasone—Acne—Estradiol—prostate cancer	0.000281	0.0107	CcSEcCtD
Desoximetasone—Erythema—Flutamide—prostate cancer	0.000259	0.0098	CcSEcCtD
Desoximetasone—NR3C1—prostate gland—prostate cancer	0.000256	0.125	CbGeAlD
Desoximetasone—Hyperglycaemia—Bicalutamide—prostate cancer	0.000243	0.0092	CcSEcCtD
Desoximetasone—Leukoderma—Epirubicin—prostate cancer	0.000242	0.00916	CcSEcCtD
Desoximetasone—Dermatitis contact—Estradiol—prostate cancer	0.000234	0.00886	CcSEcCtD
Desoximetasone—Erythema—Degarelix—prostate cancer	0.000232	0.0088	CcSEcCtD
Desoximetasone—Infection—Abiraterone—prostate cancer	0.000231	0.00874	CcSEcCtD
Desoximetasone—NR3C1—Endoderm Differentiation—FOXA1—prostate cancer	0.000229	0.0157	CbGpPWpGaD
Desoximetasone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—EGR1—prostate cancer	0.000228	0.0156	CbGpPWpGaD
Desoximetasone—Leukoderma—Doxorubicin—prostate cancer	0.000224	0.00848	CcSEcCtD
Desoximetasone—Burning sensation—Docetaxel—prostate cancer	0.000219	0.00831	CcSEcCtD
Desoximetasone—Erythema—Cabazitaxel—prostate cancer	0.000219	0.00829	CcSEcCtD
Desoximetasone—NR3C1—seminal vesicle—prostate cancer	0.000217	0.106	CbGeAlD
Desoximetasone—Pain—Estrone—prostate cancer	0.000195	0.0074	CcSEcCtD
Desoximetasone—NR3C1—SIDS Susceptibility Pathways—NKX3-1—prostate cancer	0.000191	0.0131	CbGpPWpGaD
Desoximetasone—NR3C1—Transcription factor regulation in adipogenesis—RXRA—prostate cancer	0.00019	0.013	CbGpPWpGaD
Desoximetasone—NR3C1—epithelium—prostate cancer	0.000188	0.0919	CbGeAlD
Desoximetasone—Pain—Nilutamide—prostate cancer	0.000181	0.00687	CcSEcCtD
Desoximetasone—NR3C1—Endoderm Differentiation—LAMC1—prostate cancer	0.000181	0.0124	CbGpPWpGaD
Desoximetasone—Infection—Cabazitaxel—prostate cancer	0.000177	0.00672	CcSEcCtD
Desoximetasone—NR3C1—renal system—prostate cancer	0.000175	0.0853	CbGeAlD
Desoximetasone—NR3C1—urethra—prostate cancer	0.000172	0.0837	CbGeAlD
Desoximetasone—Pain—Estradiol valerate/Dienogest—prostate cancer	0.00017	0.00646	CcSEcCtD
Desoximetasone—Pruritus—Estramustine—prostate cancer	0.000169	0.00641	CcSEcCtD
Desoximetasone—Hyperglycaemia—Goserelin—prostate cancer	0.000169	0.0064	CcSEcCtD
Desoximetasone—Hyperglycaemia—Conjugated Estrogens—prostate cancer	0.000167	0.00634	CcSEcCtD
Desoximetasone—NR3C1—Adipogenesis—KLF6—prostate cancer	0.000167	0.0115	CbGpPWpGaD
Desoximetasone—NR3C1—Adipogenesis—LIFR—prostate cancer	0.000167	0.0115	CbGpPWpGaD
Desoximetasone—NR3C1—AP-1 transcription factor network—MT2A—prostate cancer	0.000166	0.0114	CbGpPWpGaD
Desoximetasone—Folliculitis—Epirubicin—prostate cancer	0.000164	0.0062	CcSEcCtD
Desoximetasone—Psoriasis—Epirubicin—prostate cancer	0.000164	0.0062	CcSEcCtD
Desoximetasone—Glycosuria—Prednisone—prostate cancer	0.000162	0.00615	CcSEcCtD
Desoximetasone—Pain—Degarelix—prostate cancer	0.000162	0.00614	CcSEcCtD
Desoximetasone—Pruritus—Estrone—prostate cancer	0.000162	0.00612	CcSEcCtD
Desoximetasone—Amcinonide—ANXA1—prostate cancer	0.000161	0.0738	CrCbGaD
Desoximetasone—NR3C1—AP-1 transcription factor network—PENK—prostate cancer	0.000158	0.0108	CbGpPWpGaD
Desoximetasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—LAMC1—prostate cancer	0.000157	0.0108	CbGpPWpGaD
Desoximetasone—Acne—Prednisone—prostate cancer	0.000156	0.00592	CcSEcCtD
Desoximetasone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NCOA2—prostate cancer	0.000156	0.0107	CbGpPWpGaD
Desoximetasone—Pain—Cabazitaxel—prostate cancer	0.000153	0.00578	CcSEcCtD
Desoximetasone—Infection—Bicalutamide—prostate cancer	0.000152	0.00576	CcSEcCtD
Desoximetasone—Psoriasis—Doxorubicin—prostate cancer	0.000151	0.00573	CcSEcCtD
Desoximetasone—Folliculitis—Doxorubicin—prostate cancer	0.000151	0.00573	CcSEcCtD
Desoximetasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—RUNX1—prostate cancer	0.000151	0.0103	CbGpPWpGaD
Desoximetasone—Dermatitis—Estramustine—prostate cancer	0.000151	0.0057	CcSEcCtD
Desoximetasone—Pruritus—Nilutamide—prostate cancer	0.00015	0.00568	CcSEcCtD
Desoximetasone—Pruritus—Flutamide—prostate cancer	0.000149	0.00566	CcSEcCtD
Desoximetasone—Burning sensation—Epirubicin—prostate cancer	0.000148	0.00561	CcSEcCtD
Desoximetasone—NR3C1—Endoderm Differentiation—BMP7—prostate cancer	0.000148	0.0101	CbGpPWpGaD
Desoximetasone—NR3C1—Endoderm Differentiation—HNF1B—prostate cancer	0.000148	0.0101	CbGpPWpGaD
Desoximetasone—Dermatitis—Abiraterone—prostate cancer	0.000146	0.00554	CcSEcCtD
Desoximetasone—Dermatitis—Estrone—prostate cancer	0.000144	0.00545	CcSEcCtD
Desoximetasone—NR3C1—Adipogenesis—ID3—prostate cancer	0.000142	0.00974	CbGpPWpGaD
Desoximetasone—Pruritus—Estradiol valerate/Dienogest—prostate cancer	0.000141	0.00534	CcSEcCtD
Desoximetasone—NR3C1—Nuclear Receptors—ESR2—prostate cancer	0.00014	0.00957	CbGpPWpGaD
Desoximetasone—NR3C1—Transcription factor regulation in adipogenesis—LEP—prostate cancer	0.000138	0.00942	CbGpPWpGaD
Desoximetasone—Burning sensation—Doxorubicin—prostate cancer	0.000137	0.00519	CcSEcCtD
Desoximetasone—Pruritus—Degarelix—prostate cancer	0.000134	0.00508	CcSEcCtD
Desoximetasone—Hyperglycaemia—Estradiol—prostate cancer	0.000134	0.00507	CcSEcCtD
Desoximetasone—Dermatitis—Nilutamide—prostate cancer	0.000134	0.00506	CcSEcCtD
Desoximetasone—Dermatitis—Flutamide—prostate cancer	0.000133	0.00504	CcSEcCtD
Desoximetasone—NR3C1—bone marrow—prostate cancer	0.000132	0.0645	CbGeAlD
Desoximetasone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NCOA1—prostate cancer	0.000132	0.00901	CbGpPWpGaD
Desoximetasone—Pain—Bicalutamide—prostate cancer	0.000131	0.00496	CcSEcCtD
Desoximetasone—Erythema—Goserelin—prostate cancer	0.000131	0.00494	CcSEcCtD
Desoximetasone—Erythema—Conjugated Estrogens—prostate cancer	0.000129	0.0049	CcSEcCtD
Desoximetasone—NR3C1—SIDS Susceptibility Pathways—ASCL1—prostate cancer	0.000129	0.00882	CbGpPWpGaD
Desoximetasone—Infection—Ethinyl Estradiol—prostate cancer	0.000129	0.00487	CcSEcCtD
Desoximetasone—Stinging—Epirubicin—prostate cancer	0.000127	0.00481	CcSEcCtD
Desoximetasone—Glycosuria—Epirubicin—prostate cancer	0.000127	0.00481	CcSEcCtD
Desoximetasone—Dermatitis—Estradiol valerate/Dienogest—prostate cancer	0.000126	0.00476	CcSEcCtD
Desoximetasone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—RXRA—prostate cancer	0.000125	0.00857	CbGpPWpGaD
Desoximetasone—Hyperglycaemia—Mitoxantrone—prostate cancer	0.000125	0.00473	CcSEcCtD
Desoximetasone—NR3C1—Nuclear Receptors—AR—prostate cancer	0.000123	0.00846	CbGpPWpGaD
Desoximetasone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAP2K1—prostate cancer	0.000123	0.00846	CbGpPWpGaD
Desoximetasone—NR3C1—Transcription factor regulation in adipogenesis—IRS1—prostate cancer	0.000123	0.0084	CbGpPWpGaD
Desoximetasone—NR3C1—Nuclear Receptors—RXRA—prostate cancer	0.000123	0.00839	CbGpPWpGaD
Desoximetasone—NR3C1—AP-1 transcription factor network—NPPA—prostate cancer	0.000119	0.00818	CbGpPWpGaD
Desoximetasone—Dermatitis—Degarelix—prostate cancer	0.000119	0.00452	CcSEcCtD
Desoximetasone—Glycosuria—Doxorubicin—prostate cancer	0.000117	0.00445	CcSEcCtD
Desoximetasone—Stinging—Doxorubicin—prostate cancer	0.000117	0.00445	CcSEcCtD
Desoximetasone—NR3C1—Regulation of Androgen receptor activity—NCOA2—prostate cancer	0.000117	0.00802	CbGpPWpGaD
Desoximetasone—NR3C1—Circadian Clock—NCOA2—prostate cancer	0.000114	0.00779	CbGpPWpGaD
Desoximetasone—NR3C1—AP-1 transcription factor network—ATF3—prostate cancer	0.000113	0.00775	CbGpPWpGaD
Desoximetasone—NR3C1—testis—prostate cancer	0.000113	0.0551	CbGeAlD
Desoximetasone—NR3C1—Nuclear Receptors—VDR—prostate cancer	0.000111	0.0076	CbGpPWpGaD
Desoximetasone—NR3C1—Nuclear Receptor transcription pathway—ESR2—prostate cancer	0.00011	0.00757	CbGpPWpGaD
Desoximetasone—Pruritus—Bicalutamide—prostate cancer	0.000108	0.0041	CcSEcCtD
Desoximetasone—Infection—Goserelin—prostate cancer	0.000106	0.00401	CcSEcCtD
Desoximetasone—Infection—Conjugated Estrogens—prostate cancer	0.000105	0.00397	CcSEcCtD
Desoximetasone—NR3C1—Endoderm Differentiation—PTHLH—prostate cancer	0.000104	0.00712	CbGpPWpGaD
Desoximetasone—Erythema—Estradiol—prostate cancer	0.000103	0.00392	CcSEcCtD
Desoximetasone—Dermatitis contact—Epirubicin—prostate cancer	0.000102	0.00385	CcSEcCtD
Desoximetasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—ATF3—prostate cancer	0.000101	0.00689	CbGpPWpGaD
Desoximetasone—NR3C1—Regulation of Androgen receptor activity—EGR1—prostate cancer	0.0001	0.00686	CbGpPWpGaD
Desoximetasone—NR3C1—Adipogenesis—MIF—prostate cancer	9.95e-05	0.00681	CbGpPWpGaD
Desoximetasone—NR3C1—Regulation of Androgen receptor activity—NCOA1—prostate cancer	9.87e-05	0.00676	CbGpPWpGaD
Desoximetasone—NR3C1—Nuclear Receptor transcription pathway—AR—prostate cancer	9.76e-05	0.00668	CbGpPWpGaD
Desoximetasone—NR3C1—Nuclear Receptor transcription pathway—RXRA—prostate cancer	9.68e-05	0.00663	CbGpPWpGaD
Desoximetasone—Dermatitis—Bicalutamide—prostate cancer	9.65e-05	0.00365	CcSEcCtD
Desoximetasone—Erythema—Mitoxantrone—prostate cancer	9.64e-05	0.00365	CcSEcCtD
Desoximetasone—NR3C1—Circadian Clock—NCOA1—prostate cancer	9.58e-05	0.00656	CbGpPWpGaD
Desoximetasone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—PPARA—prostate cancer	9.56e-05	0.00655	CbGpPWpGaD
Desoximetasone—NR3C1—Endoderm Differentiation—EZH2—prostate cancer	9.47e-05	0.00648	CbGpPWpGaD
Desoximetasone—NR3C1—Regulation of Androgen receptor activity—AR—prostate cancer	9.46e-05	0.00648	CbGpPWpGaD
Desoximetasone—NR3C1—Glucocorticoid receptor regulatory network—BGLAP—prostate cancer	9.44e-05	0.00647	CbGpPWpGaD
Desoximetasone—Dermatitis contact—Doxorubicin—prostate cancer	9.4e-05	0.00356	CcSEcCtD
Desoximetasone—NR3C1—Regulation of Androgen receptor activity—RXRA—prostate cancer	9.39e-05	0.00643	CbGpPWpGaD
Desoximetasone—NR3C1—Nuclear Receptors—PPARA—prostate cancer	9.36e-05	0.00641	CbGpPWpGaD
Desoximetasone—Pruritus—Ethinyl Estradiol—prostate cancer	9.16e-05	0.00347	CcSEcCtD
Desoximetasone—NR3C1—Circadian Clock—RXRA—prostate cancer	9.11e-05	0.00624	CbGpPWpGaD
Desoximetasone—Pain—Goserelin—prostate cancer	9.11e-05	0.00345	CcSEcCtD
Desoximetasone—Pain—Conjugated Estrogens—prostate cancer	9.02e-05	0.00342	CcSEcCtD
Desoximetasone—NR3C1—Nuclear Receptor transcription pathway—VDR—prostate cancer	8.77e-05	0.006	CbGpPWpGaD
Desoximetasone—NR3C1—Glucocorticoid receptor regulatory network—PRKACB—prostate cancer	8.76e-05	0.006	CbGpPWpGaD
Desoximetasone—NR3C1—Regulation of Androgen receptor activity—SIRT1—prostate cancer	8.63e-05	0.00591	CbGpPWpGaD
Desoximetasone—NR3C1—AP-1 transcription factor network—TH—prostate cancer	8.51e-05	0.00583	CbGpPWpGaD
Desoximetasone—NR3C1—Nuclear Receptors—ESR1—prostate cancer	8.48e-05	0.00581	CbGpPWpGaD
Desoximetasone—NR3C1—Signaling events mediated by HDAC Class II—ESR1—prostate cancer	8.48e-05	0.00581	CbGpPWpGaD
Desoximetasone—Infection—Estradiol—prostate cancer	8.39e-05	0.00318	CcSEcCtD
Desoximetasone—Hyperglycaemia—Capecitabine—prostate cancer	8.35e-05	0.00316	CcSEcCtD
Desoximetasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—NCOA2—prostate cancer	8.34e-05	0.00571	CbGpPWpGaD
Desoximetasone—NR3C1—SIDS Susceptibility Pathways—HSP90B1—prostate cancer	8.3e-05	0.00569	CbGpPWpGaD
Desoximetasone—NR3C1—Glucocorticoid receptor regulatory network—NCOA2—prostate cancer	8.26e-05	0.00566	CbGpPWpGaD
Desoximetasone—NR3C1—lymph node—prostate cancer	8.19e-05	0.0399	CbGeAlD
Desoximetasone—Dermatitis—Ethinyl Estradiol—prostate cancer	8.15e-05	0.00309	CcSEcCtD
Desoximetasone—NR3C1—AP-1 transcription factor network—EGR1—prostate cancer	8.02e-05	0.00549	CbGpPWpGaD
Desoximetasone—Infection—Mitoxantrone—prostate cancer	7.82e-05	0.00296	CcSEcCtD
Desoximetasone—NR3C1—AP-1 transcription factor network—GJA1—prostate cancer	7.64e-05	0.00523	CbGpPWpGaD
Desoximetasone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—CREBBP—prostate cancer	7.59e-05	0.0052	CbGpPWpGaD
Desoximetasone—Pruritus—Goserelin—prostate cancer	7.54e-05	0.00285	CcSEcCtD
Desoximetasone—NR3C1—Adipogenesis—AHR—prostate cancer	7.47e-05	0.00512	CbGpPWpGaD
Desoximetasone—Pruritus—Conjugated Estrogens—prostate cancer	7.46e-05	0.00283	CcSEcCtD
Desoximetasone—Hyperglycaemia—Prednisone—prostate cancer	7.44e-05	0.00282	CcSEcCtD
Desoximetasone—NR3C1—Nuclear Receptor transcription pathway—PPARA—prostate cancer	7.4e-05	0.00506	CbGpPWpGaD
Desoximetasone—Pain—Estradiol—prostate cancer	7.22e-05	0.00274	CcSEcCtD
Desoximetasone—NR3C1—Generic Transcription Pathway—ZNF160—prostate cancer	7.18e-05	0.00492	CbGpPWpGaD
Desoximetasone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—SERPINE1—prostate cancer	7.12e-05	0.00487	CbGpPWpGaD
Desoximetasone—NR3C1—Glucocorticoid receptor regulatory network—EGR1—prostate cancer	7.07e-05	0.00484	CbGpPWpGaD
Desoximetasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—NCOA1—prostate cancer	7.03e-05	0.00481	CbGpPWpGaD
Desoximetasone—NR3C1—Circadian Clock—PPARA—prostate cancer	6.96e-05	0.00477	CbGpPWpGaD
Desoximetasone—NR3C1—Glucocorticoid receptor regulatory network—NCOA1—prostate cancer	6.96e-05	0.00477	CbGpPWpGaD
Desoximetasone—Hydrocortisone—ANXA1—prostate cancer	6.79e-05	0.0311	CrCbGaD
Desoximetasone—NR3C1—Circadian Clock—HIF1A—prostate cancer	6.77e-05	0.00463	CbGpPWpGaD
Desoximetasone—NR3C1—FOXA2 and FOXA3 transcription factor networks—INS—prostate cancer	6.75e-05	0.00462	CbGpPWpGaD
Desoximetasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AR—prostate cancer	6.74e-05	0.00462	CbGpPWpGaD
Desoximetasone—Pain—Mitoxantrone—prostate cancer	6.73e-05	0.00255	CcSEcCtD
Desoximetasone—Dermatitis—Goserelin—prostate cancer	6.71e-05	0.00254	CcSEcCtD
Desoximetasone—NR3C1—Nuclear Receptor transcription pathway—ESR1—prostate cancer	6.7e-05	0.00459	CbGpPWpGaD
Desoximetasone—Erythema—Docetaxel—prostate cancer	6.66e-05	0.00252	CcSEcCtD
Desoximetasone—Dermatitis—Conjugated Estrogens—prostate cancer	6.65e-05	0.00252	CcSEcCtD
Desoximetasone—NR3C1—AP-1 transcription factor network—IL10—prostate cancer	6.62e-05	0.00453	CbGpPWpGaD
Desoximetasone—Infection—Etoposide—prostate cancer	6.5e-05	0.00246	CcSEcCtD
Desoximetasone—Testolactone—CYP19A1—prostate cancer	6.48e-05	0.0297	CrCbGaD
Desoximetasone—Erythema—Capecitabine—prostate cancer	6.45e-05	0.00244	CcSEcCtD
Desoximetasone—Dexamethasone—CYP3A43—prostate cancer	6.4e-05	0.0293	CrCbGaD
Desoximetasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—VDR—prostate cancer	6.06e-05	0.00415	CbGpPWpGaD
Desoximetasone—Pruritus—Estradiol—prostate cancer	5.97e-05	0.00226	CcSEcCtD
Desoximetasone—NR3C1—Regulation of Androgen receptor activity—GSK3B—prostate cancer	5.89e-05	0.00404	CbGpPWpGaD
Desoximetasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—prostate cancer	5.89e-05	0.00403	CbGpPWpGaD
Desoximetasone—Hyperglycaemia—Epirubicin—prostate cancer	5.82e-05	0.0022	CcSEcCtD
Desoximetasone—Erythema—Prednisone—prostate cancer	5.75e-05	0.00218	CcSEcCtD
Desoximetasone—NR3C1—Adipogenesis—NCOA2—prostate cancer	5.71e-05	0.00391	CbGpPWpGaD
Desoximetasone—NR3C1—Regulation of Androgen receptor activity—CREBBP—prostate cancer	5.69e-05	0.0039	CbGpPWpGaD
Desoximetasone—NR3C1—Glucocorticoid receptor regulatory network—BAX—prostate cancer	5.68e-05	0.00389	CbGpPWpGaD
Desoximetasone—Pain—Etoposide—prostate cancer	5.6e-05	0.00212	CcSEcCtD
Desoximetasone—NR3C1—AP-1 transcription factor network—HIF1A—prostate cancer	5.58e-05	0.00382	CbGpPWpGaD
Desoximetasone—NR3C1—Adipogenesis—GADD45A—prostate cancer	5.54e-05	0.00379	CbGpPWpGaD
Desoximetasone—NR3C1—Circadian Clock—CREBBP—prostate cancer	5.53e-05	0.00379	CbGpPWpGaD
Desoximetasone—NR3C1—AP-1 transcription factor network—PLAU—prostate cancer	5.53e-05	0.00378	CbGpPWpGaD
Desoximetasone—Difluprednate—NR3C1—prostate cancer	5.41e-05	0.0248	CrCbGaD
Desoximetasone—Infection—Docetaxel—prostate cancer	5.4e-05	0.00205	CcSEcCtD
Desoximetasone—Hyperglycaemia—Doxorubicin—prostate cancer	5.38e-05	0.00204	CcSEcCtD
Desoximetasone—Dermatitis—Estradiol—prostate cancer	5.32e-05	0.00202	CcSEcCtD
Desoximetasone—Clocortolone—NR3C1—prostate cancer	5.25e-05	0.024	CrCbGaD
Desoximetasone—NR3C1—SIDS Susceptibility Pathways—PRKACB—prostate cancer	5.24e-05	0.00359	CbGpPWpGaD
Desoximetasone—Infection—Capecitabine—prostate cancer	5.23e-05	0.00198	CcSEcCtD
Desoximetasone—NR3C1—AP-1 transcription factor network—ESR1—prostate cancer	5.2e-05	0.00356	CbGpPWpGaD
Desoximetasone—NR3C1—Circadian Clock—SERPINE1—prostate cancer	5.18e-05	0.00355	CbGpPWpGaD
Desoximetasone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—prostate cancer	5.17e-05	0.00354	CbGpPWpGaD
Desoximetasone—NR3C1—Transcription factor regulation in adipogenesis—IL6—prostate cancer	5.13e-05	0.00352	CbGpPWpGaD
Desoximetasone—Dexamethasone—ANXA1—prostate cancer	5.06e-05	0.0232	CrCbGaD
Desoximetasone—NR3C1—Endoderm Differentiation—APC—prostate cancer	5.03e-05	0.00345	CbGpPWpGaD
Desoximetasone—NR3C1—Generic Transcription Pathway—TBX5—prostate cancer	4.98e-05	0.00341	CbGpPWpGaD
Desoximetasone—Diflorasone—NR3C1—prostate cancer	4.96e-05	0.0228	CrCbGaD
Desoximetasone—Desonide—NR3C1—prostate cancer	4.96e-05	0.0228	CrCbGaD
Desoximetasone—Dermatitis—Mitoxantrone—prostate cancer	4.96e-05	0.00188	CcSEcCtD
Desoximetasone—NR3C1—SIDS Susceptibility Pathways—IL1RN—prostate cancer	4.87e-05	0.00334	CbGpPWpGaD
Desoximetasone—NR3C1—Regulation of Androgen receptor activity—MDM2—prostate cancer	4.84e-05	0.00331	CbGpPWpGaD
Desoximetasone—NR3C1—Adipogenesis—NCOA1—prostate cancer	4.81e-05	0.0033	CbGpPWpGaD
Desoximetasone—Loteprednol—NR3C1—prostate cancer	4.78e-05	0.0219	CrCbGaD
Desoximetasone—Fludrocortisone—AR—prostate cancer	4.72e-05	0.0216	CrCbGaD
Desoximetasone—Infection—Prednisone—prostate cancer	4.66e-05	0.00177	CcSEcCtD
Desoximetasone—Pain—Docetaxel—prostate cancer	4.65e-05	0.00176	CcSEcCtD
Desoximetasone—Pruritus—Etoposide—prostate cancer	4.63e-05	0.00175	CcSEcCtD
Desoximetasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—prostate cancer	4.63e-05	0.00317	CbGpPWpGaD
Desoximetasone—NR3C1—Adipogenesis—RXRA—prostate cancer	4.58e-05	0.00314	CbGpPWpGaD
Desoximetasone—Beclomethasone—CYP3A5—prostate cancer	4.53e-05	0.0208	CrCbGaD
Desoximetasone—NR3C1—SIDS Susceptibility Pathways—ESR2—prostate cancer	4.52e-05	0.00309	CbGpPWpGaD
Desoximetasone—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—prostate cancer	4.51e-05	0.00309	CbGpPWpGaD
Desoximetasone—Pain—Capecitabine—prostate cancer	4.5e-05	0.00171	CcSEcCtD
Desoximetasone—Erythema—Epirubicin—prostate cancer	4.49e-05	0.0017	CcSEcCtD
Desoximetasone—NR3C1—SIDS Susceptibility Pathways—TH—prostate cancer	4.48e-05	0.00307	CbGpPWpGaD
Desoximetasone—Fluoxymesterone—SHBG—prostate cancer	4.44e-05	0.0204	CrCbGaD
Desoximetasone—NR3C1—SIDS Susceptibility Pathways—EGR1—prostate cancer	4.22e-05	0.00289	CbGpPWpGaD
Desoximetasone—Flumethasone Pivalate—NR3C1—prostate cancer	4.17e-05	0.0191	CrCbGaD
Desoximetasone—Erythema—Doxorubicin—prostate cancer	4.16e-05	0.00158	CcSEcCtD
Desoximetasone—NR3C1—Glucocorticoid receptor regulatory network—GSK3B—prostate cancer	4.16e-05	0.00285	CbGpPWpGaD
Desoximetasone—Dermatitis—Etoposide—prostate cancer	4.12e-05	0.00156	CcSEcCtD
Desoximetasone—Halobetasol Propionate—NR3C1—prostate cancer	4.1e-05	0.0188	CrCbGaD
Desoximetasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CREBBP—prostate cancer	4.06e-05	0.00278	CbGpPWpGaD
Desoximetasone—NR3C1—SIDS Susceptibility Pathways—GJA1—prostate cancer	4.02e-05	0.00275	CbGpPWpGaD
Desoximetasone—NR3C1—Glucocorticoid receptor regulatory network—CREBBP—prostate cancer	4.02e-05	0.00275	CbGpPWpGaD
Desoximetasone—NR3C1—SIDS Susceptibility Pathways—AR—prostate cancer	3.99e-05	0.00273	CbGpPWpGaD
Desoximetasone—NR3C1—Adipogenesis—LPL—prostate cancer	3.96e-05	0.00271	CbGpPWpGaD
Desoximetasone—Fluoxymesterone—AR—prostate cancer	3.9e-05	0.0179	CrCbGaD
Desoximetasone—NR3C1—Regulation of Androgen receptor activity—EP300—prostate cancer	3.88e-05	0.00266	CbGpPWpGaD
Desoximetasone—Pruritus—Docetaxel—prostate cancer	3.85e-05	0.00146	CcSEcCtD
Desoximetasone—Budesonide—NR3C1—prostate cancer	3.81e-05	0.0175	CrCbGaD
Desoximetasone—Amcinonide—NR3C1—prostate cancer	3.81e-05	0.0175	CrCbGaD
Desoximetasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—prostate cancer	3.8e-05	0.0026	CbGpPWpGaD
Desoximetasone—NR3C1—Regulation of Androgen receptor activity—SRC—prostate cancer	3.77e-05	0.00258	CbGpPWpGaD
Desoximetasone—NR3C1—Circadian Clock—EP300—prostate cancer	3.76e-05	0.00258	CbGpPWpGaD
Desoximetasone—Fluticasone furoate—NR3C1—prostate cancer	3.74e-05	0.0171	CrCbGaD
Desoximetasone—Pruritus—Capecitabine—prostate cancer	3.73e-05	0.00141	CcSEcCtD
Desoximetasone—Infection—Epirubicin—prostate cancer	3.64e-05	0.00138	CcSEcCtD
Desoximetasone—Mometasone—NR3C1—prostate cancer	3.63e-05	0.0166	CrCbGaD
Desoximetasone—NR3C1—AP-1 transcription factor network—CXCL8—prostate cancer	3.62e-05	0.00248	CbGpPWpGaD
Desoximetasone—Rimexolone—NR3C1—prostate cancer	3.58e-05	0.0164	CrCbGaD
Desoximetasone—NR3C1—AP-1 transcription factor network—CDKN1B—prostate cancer	3.54e-05	0.00242	CbGpPWpGaD
Desoximetasone—NR3C1—Adipogenesis—PPARA—prostate cancer	3.5e-05	0.0024	CbGpPWpGaD
Desoximetasone—NR3C1—SIDS Susceptibility Pathways—IL10—prostate cancer	3.49e-05	0.00239	CbGpPWpGaD
Desoximetasone—NR3C1—AP-1 transcription factor network—IL2—prostate cancer	3.46e-05	0.00237	CbGpPWpGaD
Desoximetasone—NR3C1—Gene Expression—SSR2—prostate cancer	3.46e-05	0.00237	CbGpPWpGaD
Desoximetasone—NR3C1—Gene Expression—BAZ2A—prostate cancer	3.46e-05	0.00237	CbGpPWpGaD
Desoximetasone—NR3C1—Gene Expression—ZNF160—prostate cancer	3.46e-05	0.00237	CbGpPWpGaD
Desoximetasone—Dermatitis—Docetaxel—prostate cancer	3.43e-05	0.0013	CcSEcCtD
Desoximetasone—NR3C1—Endoderm Differentiation—CTNNB1—prostate cancer	3.42e-05	0.00234	CbGpPWpGaD
Desoximetasone—NR3C1—Glucocorticoid receptor regulatory network—MDM2—prostate cancer	3.41e-05	0.00234	CbGpPWpGaD
Desoximetasone—NR3C1—Adipogenesis—HIF1A—prostate cancer	3.4e-05	0.00233	CbGpPWpGaD
Desoximetasone—Beclomethasone—NR3C1—prostate cancer	3.38e-05	0.0155	CrCbGaD
Desoximetasone—Fluocinonide—NR3C1—prostate cancer	3.38e-05	0.0155	CrCbGaD
Desoximetasone—NR3C1—AP-1 transcription factor network—CCND1—prostate cancer	3.37e-05	0.00231	CbGpPWpGaD
Desoximetasone—Infection—Doxorubicin—prostate cancer	3.37e-05	0.00128	CcSEcCtD
Desoximetasone—NR3C1—AP-1 transcription factor network—CTNNB1—prostate cancer	3.34e-05	0.00229	CbGpPWpGaD
Desoximetasone—NR3C1—Adipogenesis—LEP—prostate cancer	3.32e-05	0.00227	CbGpPWpGaD
Desoximetasone—Pruritus—Prednisone—prostate cancer	3.32e-05	0.00126	CcSEcCtD
Desoximetasone—Dermatitis—Capecitabine—prostate cancer	3.32e-05	0.00126	CcSEcCtD
Desoximetasone—Fluocinolone Acetonide—NR3C1—prostate cancer	3.29e-05	0.0151	CrCbGaD
Desoximetasone—Alclometasone—NR3C1—prostate cancer	3.29e-05	0.0151	CrCbGaD
Desoximetasone—NR3C1—AP-1 transcription factor network—MMP9—prostate cancer	3.27e-05	0.00224	CbGpPWpGaD
Desoximetasone—NR3C1—AP-1 transcription factor network—PTEN—prostate cancer	3.25e-05	0.00223	CbGpPWpGaD
Desoximetasone—Clobetasol propionate—NR3C1—prostate cancer	3.2e-05	0.0147	CrCbGaD
Desoximetasone—Fludrocortisone—NR3C1—prostate cancer	3.2e-05	0.0147	CrCbGaD
Desoximetasone—Flunisolide—NR3C1—prostate cancer	3.2e-05	0.0147	CrCbGaD
Desoximetasone—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—prostate cancer	3.19e-05	0.00218	CbGpPWpGaD
Desoximetasone—NR3C1—Gene Expression—HNRNPH1—prostate cancer	3.16e-05	0.00217	CbGpPWpGaD
Desoximetasone—Paramethasone—NR3C1—prostate cancer	3.16e-05	0.0145	CrCbGaD
Desoximetasone—Pain—Epirubicin—prostate cancer	3.14e-05	0.00119	CcSEcCtD
Desoximetasone—NR3C1—AP-1 transcription factor network—EP300—prostate cancer	3.1e-05	0.00213	CbGpPWpGaD
Desoximetasone—Fluorometholone—NR3C1—prostate cancer	3.08e-05	0.0141	CrCbGaD
Desoximetasone—NR3C1—Glucocorticoid receptor regulatory network—IL2—prostate cancer	3.05e-05	0.00209	CbGpPWpGaD
Desoximetasone—Fluticasone Propionate—CYP3A5—prostate cancer	3.01e-05	0.0138	CrCbGaD
Desoximetasone—Fluoxymesterone—ESR1—prostate cancer	3e-05	0.0138	CrCbGaD
Desoximetasone—Methylprednisolone—NR3C1—prostate cancer	2.98e-05	0.0137	CrCbGaD
Desoximetasone—NR3C1—Adipogenesis—IRS1—prostate cancer	2.96e-05	0.00203	CbGpPWpGaD
Desoximetasone—Dermatitis—Prednisone—prostate cancer	2.95e-05	0.00112	CcSEcCtD
Desoximetasone—NR3C1—Gene Expression—NFIC—prostate cancer	2.94e-05	0.00201	CbGpPWpGaD
Desoximetasone—NR3C1—SIDS Susceptibility Pathways—HIF1A—prostate cancer	2.94e-05	0.00201	CbGpPWpGaD
Desoximetasone—Clobetasol propionate—CYP1A1—prostate cancer	2.9e-05	0.0133	CrCbGaD
Desoximetasone—Dexamethasone—CYP17A1—prostate cancer	2.9e-05	0.0133	CrCbGaD
Desoximetasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—prostate cancer	2.9e-05	0.00199	CbGpPWpGaD
Desoximetasone—Pain—Doxorubicin—prostate cancer	2.9e-05	0.0011	CcSEcCtD
Desoximetasone—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—prostate cancer	2.87e-05	0.00197	CbGpPWpGaD
Desoximetasone—NR3C1—Adipogenesis—INS—prostate cancer	2.84e-05	0.00194	CbGpPWpGaD
Desoximetasone—NR3C1—Gene Expression—RPN2—prostate cancer	2.76e-05	0.00189	CbGpPWpGaD
Desoximetasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—prostate cancer	2.76e-05	0.00189	CbGpPWpGaD
Desoximetasone—NR3C1—Endoderm Differentiation—TGFB1—prostate cancer	2.76e-05	0.00189	CbGpPWpGaD
Desoximetasone—NR3C1—Adipogenesis—IGF1—prostate cancer	2.74e-05	0.00188	CbGpPWpGaD
Desoximetasone—NR3C1—Glucocorticoid receptor regulatory network—EP300—prostate cancer	2.74e-05	0.00187	CbGpPWpGaD
Desoximetasone—Prednisolone—CYP2A6—prostate cancer	2.72e-05	0.0125	CrCbGaD
Desoximetasone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—prostate cancer	2.72e-05	0.00186	CbGpPWpGaD
Desoximetasone—NR3C1—AP-1 transcription factor network—MYC—prostate cancer	2.7e-05	0.00185	CbGpPWpGaD
Desoximetasone—Hydrocortisone—SHBG—prostate cancer	2.7e-05	0.0124	CrCbGaD
Desoximetasone—NR3C1—AP-1 transcription factor network—TGFB1—prostate cancer	2.7e-05	0.00185	CbGpPWpGaD
Desoximetasone—NR3C1—Generic Transcription Pathway—NPPA—prostate cancer	2.66e-05	0.00182	CbGpPWpGaD
Desoximetasone—Fluoxymesterone—NR3C1—prostate cancer	2.64e-05	0.0121	CrCbGaD
Desoximetasone—NR3C1—Gene Expression—QARS—prostate cancer	2.62e-05	0.00179	CbGpPWpGaD
Desoximetasone—NR3C1—Generic Transcription Pathway—MED12—prostate cancer	2.62e-05	0.00179	CbGpPWpGaD
Desoximetasone—NR3C1—Adipogenesis—SERPINE1—prostate cancer	2.6e-05	0.00178	CbGpPWpGaD
Desoximetasone—Pruritus—Epirubicin—prostate cancer	2.6e-05	0.000983	CcSEcCtD
Desoximetasone—Betamethasone—CYP19A1—prostate cancer	2.54e-05	0.0116	CrCbGaD
Desoximetasone—Triamcinolone—NR3C1—prostate cancer	2.51e-05	0.0115	CrCbGaD
Desoximetasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—prostate cancer	2.41e-05	0.00165	CbGpPWpGaD
Desoximetasone—Pruritus—Doxorubicin—prostate cancer	2.4e-05	0.00091	CcSEcCtD
Desoximetasone—NR3C1—SIDS Susceptibility Pathways—CREBBP—prostate cancer	2.4e-05	0.00164	CbGpPWpGaD
Desoximetasone—NR3C1—Gene Expression—TBX5—prostate cancer	2.4e-05	0.00164	CbGpPWpGaD
Desoximetasone—Dermatitis—Epirubicin—prostate cancer	2.31e-05	0.000875	CcSEcCtD
Desoximetasone—Prednisone—NR3C1—prostate cancer	2.28e-05	0.0104	CrCbGaD
Desoximetasone—Fluticasone Propionate—NR3C1—prostate cancer	2.25e-05	0.0103	CrCbGaD
Desoximetasone—NR3C1—Gene Expression—EIF3H—prostate cancer	2.23e-05	0.00153	CbGpPWpGaD
Desoximetasone—NR3C1—AP-1 transcription factor network—TP53—prostate cancer	2.22e-05	0.00152	CbGpPWpGaD
Desoximetasone—Budesonide—CYP3A4—prostate cancer	2.21e-05	0.0101	CrCbGaD
Desoximetasone—Fluticasone furoate—CYP3A4—prostate cancer	2.17e-05	0.00993	CrCbGaD
Desoximetasone—Hydrocortisone—CYP3A5—prostate cancer	2.15e-05	0.00986	CrCbGaD
Desoximetasone—Dermatitis—Doxorubicin—prostate cancer	2.14e-05	0.00081	CcSEcCtD
Desoximetasone—Prednisolone—NR3C1—prostate cancer	2.1e-05	0.00963	CrCbGaD
Desoximetasone—NR3C1—Generic Transcription Pathway—NCOA2—prostate cancer	2.09e-05	0.00143	CbGpPWpGaD
Desoximetasone—Prednisone—CYP2C19—prostate cancer	2.08e-05	0.00952	CrCbGaD
Desoximetasone—Betamethasone—NR3C1—prostate cancer	2.06e-05	0.00943	CrCbGaD
Desoximetasone—NR3C1—Adipogenesis—CTNNB1—prostate cancer	2.04e-05	0.00139	CbGpPWpGaD
Desoximetasone—NR3C1—AP-1 transcription factor network—IL6—prostate cancer	2.03e-05	0.00139	CbGpPWpGaD
Desoximetasone—NR3C1—Generic Transcription Pathway—PARP1—prostate cancer	2.01e-05	0.00138	CbGpPWpGaD
Desoximetasone—Dexamethasone—CYP1B1—prostate cancer	2.01e-05	0.00923	CrCbGaD
Desoximetasone—NR3C1—Adipogenesis—CDKN1A—prostate cancer	1.99e-05	0.00136	CbGpPWpGaD
Desoximetasone—NR3C1—Glucocorticoid receptor regulatory network—TP53—prostate cancer	1.96e-05	0.00134	CbGpPWpGaD
Desoximetasone—NR3C1—Generic Transcription Pathway—ESR2—prostate cancer	1.91e-05	0.00131	CbGpPWpGaD
Desoximetasone—NR3C1—SIDS Susceptibility Pathways—CXCL8—prostate cancer	1.91e-05	0.00131	CbGpPWpGaD
Desoximetasone—Alclometasone—CYP3A4—prostate cancer	1.9e-05	0.00873	CrCbGaD
Desoximetasone—Flunisolide—CYP3A4—prostate cancer	1.85e-05	0.0085	CrCbGaD
Desoximetasone—Paramethasone—CYP3A4—prostate cancer	1.83e-05	0.00839	CrCbGaD
Desoximetasone—NR3C1—SIDS Susceptibility Pathways—CASP3—prostate cancer	1.82e-05	0.00125	CbGpPWpGaD
Desoximetasone—NR3C1—Gene Expression—TET2—prostate cancer	1.82e-05	0.00124	CbGpPWpGaD
Desoximetasone—NR3C1—Gene Expression—MBD2—prostate cancer	1.82e-05	0.00124	CbGpPWpGaD
Desoximetasone—NR3C1—Glucocorticoid receptor regulatory network—IL6—prostate cancer	1.79e-05	0.00123	CbGpPWpGaD
Desoximetasone—Fluorometholone—CYP3A4—prostate cancer	1.79e-05	0.00819	CrCbGaD
Desoximetasone—NR3C1—Gene Expression—RPL12—prostate cancer	1.78e-05	0.00122	CbGpPWpGaD
Desoximetasone—NR3C1—Adipogenesis—STAT3—prostate cancer	1.77e-05	0.00121	CbGpPWpGaD
Desoximetasone—NR3C1—SIDS Susceptibility Pathways—CTNNB1—prostate cancer	1.76e-05	0.0012	CbGpPWpGaD
Desoximetasone—NR3C1—Generic Transcription Pathway—NCOA1—prostate cancer	1.76e-05	0.0012	CbGpPWpGaD
Desoximetasone—Methylprednisolone—CYP3A4—prostate cancer	1.73e-05	0.00792	CrCbGaD
Desoximetasone—NR3C1—Generic Transcription Pathway—AR—prostate cancer	1.69e-05	0.00115	CbGpPWpGaD
Desoximetasone—NR3C1—Generic Transcription Pathway—RXRA—prostate cancer	1.67e-05	0.00115	CbGpPWpGaD
Desoximetasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—prostate cancer	1.67e-05	0.00114	CbGpPWpGaD
Desoximetasone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—prostate cancer	1.65e-05	0.00113	CbGpPWpGaD
Desoximetasone—NR3C1—Adipogenesis—TGFB1—prostate cancer	1.64e-05	0.00113	CbGpPWpGaD
Desoximetasone—NR3C1—Gene Expression—EIF3A—prostate cancer	1.64e-05	0.00112	CbGpPWpGaD
Desoximetasone—NR3C1—SIDS Susceptibility Pathways—EP300—prostate cancer	1.64e-05	0.00112	CbGpPWpGaD
Desoximetasone—Hydrocortisone—NR3C1—prostate cancer	1.61e-05	0.00737	CrCbGaD
Desoximetasone—Dexamethasone—CYP3A5—prostate cancer	1.6e-05	0.00735	CrCbGaD
Desoximetasone—Dexamethasone—CYP2A6—prostate cancer	1.55e-05	0.00711	CrCbGaD
Desoximetasone—NR3C1—SIDS Susceptibility Pathways—VEGFA—prostate cancer	1.55e-05	0.00106	CbGpPWpGaD
Desoximetasone—NR3C1—Generic Transcription Pathway—VDR—prostate cancer	1.51e-05	0.00104	CbGpPWpGaD
Desoximetasone—Dexamethasone—CYP19A1—prostate cancer	1.48e-05	0.00677	CrCbGaD
Desoximetasone—Triamcinolone—CYP3A4—prostate cancer	1.46e-05	0.00668	CrCbGaD
Desoximetasone—Triamcinolone—PTGS2—prostate cancer	1.43e-05	0.00654	CrCbGaD
Desoximetasone—NR3C1—Gene Expression—DNMT3B—prostate cancer	1.38e-05	0.000943	CbGpPWpGaD
Desoximetasone—NR3C1—Gene Expression—RPL10—prostate cancer	1.35e-05	0.000925	CbGpPWpGaD
Desoximetasone—NR3C1—Gene Expression—HIST1H2BG—prostate cancer	1.33e-05	0.000908	CbGpPWpGaD
Desoximetasone—Prednisone—CYP3A4—prostate cancer	1.32e-05	0.00606	CrCbGaD
Desoximetasone—Fluticasone Propionate—CYP3A4—prostate cancer	1.3e-05	0.00597	CrCbGaD
Desoximetasone—NR3C1—Gene Expression—HIST1H4H—prostate cancer	1.28e-05	0.000877	CbGpPWpGaD
Desoximetasone—NR3C1—Gene Expression—NPPA—prostate cancer	1.28e-05	0.000877	CbGpPWpGaD
Desoximetasone—NR3C1—Generic Transcription Pathway—PPARA—prostate cancer	1.28e-05	0.000875	CbGpPWpGaD
Desoximetasone—NR3C1—Gene Expression—MED12—prostate cancer	1.26e-05	0.000862	CbGpPWpGaD
Desoximetasone—NR3C1—Adipogenesis—IL6—prostate cancer	1.24e-05	0.000849	CbGpPWpGaD
Desoximetasone—Prednisolone—CYP3A4—prostate cancer	1.22e-05	0.00558	CrCbGaD
Desoximetasone—Dexamethasone—NR3C1—prostate cancer	1.2e-05	0.00549	CrCbGaD
Desoximetasone—Betamethasone—CYP3A4—prostate cancer	1.19e-05	0.00547	CrCbGaD
Desoximetasone—Betamethasone—PTGS2—prostate cancer	1.17e-05	0.00535	CrCbGaD
Desoximetasone—NR3C1—Generic Transcription Pathway—ESR1—prostate cancer	1.16e-05	0.000793	CbGpPWpGaD
Desoximetasone—Dexamethasone—CYP2E1—prostate cancer	1.1e-05	0.00505	CrCbGaD
Desoximetasone—Dexamethasone—CYP2C19—prostate cancer	1.09e-05	0.005	CrCbGaD
Desoximetasone—Dexamethasone—CYP1A1—prostate cancer	1.09e-05	0.00498	CrCbGaD
Desoximetasone—NR3C1—SIDS Susceptibility Pathways—IL6—prostate cancer	1.07e-05	0.000733	CbGpPWpGaD
Desoximetasone—NR3C1—Gene Expression—RPS19—prostate cancer	1.07e-05	0.000733	CbGpPWpGaD
Desoximetasone—NR3C1—Gene Expression—DNMT1—prostate cancer	1.02e-05	0.000701	CbGpPWpGaD
Desoximetasone—NR3C1—Generic Transcription Pathway—CREBBP—prostate cancer	1.01e-05	0.000695	CbGpPWpGaD
Desoximetasone—NR3C1—Gene Expression—NCOA2—prostate cancer	1e-05	0.000688	CbGpPWpGaD
Desoximetasone—NR3C1—Gene Expression—EZH2—prostate cancer	9.91e-06	0.000679	CbGpPWpGaD
Desoximetasone—NR3C1—Gene Expression—PARP1—prostate cancer	9.7e-06	0.000664	CbGpPWpGaD
Desoximetasone—NR3C1—Generic Transcription Pathway—SERPINE1—prostate cancer	9.51e-06	0.000651	CbGpPWpGaD
Desoximetasone—Hydrocortisone—CYP3A4—prostate cancer	9.31e-06	0.00427	CrCbGaD
Desoximetasone—NR3C1—Gene Expression—ESR2—prostate cancer	9.19e-06	0.000629	CbGpPWpGaD
Desoximetasone—NR3C1—Gene Expression—HSPA1A—prostate cancer	9.19e-06	0.000629	CbGpPWpGaD
Desoximetasone—NR3C1—Gene Expression—NCOA1—prostate cancer	8.46e-06	0.00058	CbGpPWpGaD
Desoximetasone—NR3C1—Gene Expression—AR—prostate cancer	8.11e-06	0.000556	CbGpPWpGaD
Desoximetasone—NR3C1—Gene Expression—RXRA—prostate cancer	8.05e-06	0.000551	CbGpPWpGaD
Desoximetasone—NR3C1—Gene Expression—SIRT1—prostate cancer	7.4e-06	0.000507	CbGpPWpGaD
Desoximetasone—NR3C1—Gene Expression—VDR—prostate cancer	7.29e-06	0.000499	CbGpPWpGaD
Desoximetasone—Dexamethasone—CYP3A4—prostate cancer	6.94e-06	0.00318	CrCbGaD
Desoximetasone—Dexamethasone—PTGS2—prostate cancer	6.8e-06	0.00311	CrCbGaD
Desoximetasone—NR3C1—Gene Expression—ERCC2—prostate cancer	6.67e-06	0.000457	CbGpPWpGaD
Desoximetasone—NR3C1—Gene Expression—PPARA—prostate cancer	6.15e-06	0.000421	CbGpPWpGaD
Desoximetasone—NR3C1—Generic Transcription Pathway—MYC—prostate cancer	6.02e-06	0.000412	CbGpPWpGaD
Desoximetasone—NR3C1—Gene Expression—ESR1—prostate cancer	5.57e-06	0.000382	CbGpPWpGaD
Desoximetasone—NR3C1—Gene Expression—CREBBP—prostate cancer	4.88e-06	0.000334	CbGpPWpGaD
Desoximetasone—NR3C1—Gene Expression—SERPINE1—prostate cancer	4.58e-06	0.000314	CbGpPWpGaD
Desoximetasone—NR3C1—Gene Expression—MYC—prostate cancer	2.9e-06	0.000198	CbGpPWpGaD
Desoximetasone—NR3C1—Gene Expression—AKT1—prostate cancer	2.01e-06	0.000138	CbGpPWpGaD
